Exploring water, sanitation, and hygiene coverage targets for reaching and sustaining trachoma elimination: G-computation analysis
Kristin M Sullivan,Emma M Harding-Esch,Alexander P Keil,Matthew C Freeman,Wilfrid E Batcho,Amadou A Bio Issifou,Victor Bucumi,Assumpta L Bella,Emilienne Epee,Segni Bobo Barkesa,Fikre Seife Gebretsadik,Salimato Sanha,Khumbo M Kalua,Michael P Masika,Abdallahi O Minnih,Mariamo Abdala,Marília E Massangaie,Abdou Amza,Boubacar Kadri,Beido Nassirou,Caleb D Mpyet,Nicholas Olobio,Mouctar D Badiane,Balgesa E Elshafie,Gilbert Baayenda,George E Kabona,Oscar Kaitaba,Alistidia Simon,Tawfik Q Al-Khateeb,Consity Mwale,Ana Bakhtiari,Daniel Westreich,Anthony W Solomon,Emily W Gower
DOI: https://doi.org/10.1371/journal.pntd.0011103
2023-02-13
Abstract:Background: Trachoma is the leading infectious cause of blindness. To reduce transmission, water, sanitation, and hygiene (WaSH) improvements are promoted through a comprehensive public health strategy. Evidence supporting the role of WaSH in trachoma elimination is mixed and it remains unknown what WaSH coverages are needed to effectively reduce transmission. Methods/findings: We used g-computation to estimate the impact on the prevalence of trachomatous inflammation-follicular among children aged 1-9 years (TF1-9) when hypothetical WaSH interventions raised the minimum coverages from 5% to 100% for "nearby" face-washing water (<30 minutes roundtrip collection time) and adult latrine use in an evaluation unit (EU). For each scenario, we estimated the generalized prevalence difference as the TF1-9 prevalence under the intervention scenarios minus the observed prevalence. Data from 574 cross-sectional surveys conducted in 16 African and Eastern Mediterranean countries were included. Surveys were conducted from 2015-2019 with support from the Global Trachoma Mapping Project and Tropical Data. When modeling interventions among EUs that had not yet met the TF1-9 elimination target, increasing nearby face-washing water and latrine use coverages above 30% was generally associated with consistent decreases in TF1-9. For nearby face-washing water, we estimated a ≥25% decrease in TF1-9 at 65% coverage, with a plateau upon reaching 85% coverage. For latrine use, the estimated decrease in TF1-9 accelerated from 80% coverage upward, with a ≥25% decrease in TF1-9 by 85% coverage. Among EUs that had previously met the elimination target, results were inconclusive. Conclusions: Our results support Sustainable Development Goal 6 and provide insight into potential WaSH-related coverage targets for trachoma elimination. Targets can be tested in future trials to improve evidence-based WaSH guidance for trachoma.